297 filings
Page 2 of 15
8-K
Liquidia Corporation
9 Nov 20
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:20am
10-Q
2020 Q3
Liquidia Corporation
Quarterly report
6 Nov 20
4:15pm
DEFA14A
Liquidia Corporation
5 Nov 20
Additional proxy soliciting materials
7:01am
DEFA14A
Liquidia Corporation
2 Nov 20
Additional proxy soliciting materials
8:08am
8-K
Liquidia Corporation
2 Nov 20
Liquidia Reschedules Special Meeting of Stockholders and Reaffirms Recommendation to Approve Proposed Acquisition of RareGen, LLC
8:04am
DEFA14A
Liquidia Corporation
19 Oct 20
Additional proxy soliciting materials
8:37am
8-K
Liquidia Corporation
19 Oct 20
Liquidia Announces Postponement of Special Meeting of Stockholders
8:35am
8-K
Liquidia Corporation
14 Oct 20
Liquidia Provides Update on U.S. Patent Trial and Appeal Board Decision on Inter Partes Review of Two United Therapeutics’ Tyvaso® Patents
4:16pm
DEFA14A
Liquidia Corporation
8 Oct 20
Additional proxy soliciting materials
4:01pm
DEFA14A
Liquidia Corporation
18 Sep 20
Additional proxy soliciting materials
4:32pm
425
Liquidia Corporation
18 Sep 20
Business combination disclosure
4:30pm
DEFA14A
Liquidia Corporation
17 Sep 20
Additional proxy soliciting materials
7:22am
425
Liquidia Corporation
17 Sep 20
Business combination disclosure
7:20am
DEFM14A
Liquidia Corporation
17 Sep 20
Proxy related to merger
12:00am
3
Steven Bariahtaris
21 Aug 20
Liquidia / Steven Bariahtaris ownership change
7:07pm
DEFA14A
Liquidia Corporation
20 Aug 20
Additional proxy soliciting materials
9:22am
425
LQDA
Liquidia Corp
20 Aug 20
Business combination disclosure
9:21am
8-K
Liquidia Corporation
20 Aug 20
Liquidia Announces Chief Financial Officer Transition
9:20am
10-Q
2020 Q2
Liquidia Corporation
Quarterly report
10 Aug 20
4:31pm
DEFA14A
Liquidia Corporation
10 Aug 20
Additional proxy soliciting materials
7:22am